Aurobindo Pharma plans manufacturing unit in the USIllustrative image – not actual.

Aurobindo Pharma has plans to set up a manufacturing unit in Los Angeles to make sterile cephalosporins for the US market. The project is estimated to cost $8 million.

 

The project would be set up as a joint venture with MedPharmix Inc. Both partners would invest $4 million in the new venture called – Cephazone Inc.

 

The new unit is expected to become operational in the first quarter of 2003-04.

 

Meanwhile, in India, Aurobindo Pharma is setting up a bulk drugs unit in Visakhapatnam in Andhra Pradesh with an investment of Rs.35 crore. This unit is expected to commence operations in May 2002.

← All latest storiesBack to top →